Electronic Equipment and Instruments

Wingtech

Wingtech released FY2025 earnings on April 29 Pre-Market (BJT), actual revenue CNY 31.25 B (forecast CNY 33.79 B), actual EPS CNY -7.03 (forecast CNY 1.6268)

Wingtech released FY2025 Q4 earnings on April 29 Pre-Market (BJT), actual revenue CNY 1.484 B (forecast CNY 3.878 B), actual EPS CNY -8.1714 (forecast CNY 0.3439)

Wingtech released FY2026 Q1 earnings on April 29 During-Market (BJT), actual revenue CNY 816.41 M (forecast CNY 3.715 B), actual EPS CNY -0.15 (forecast CNY 0.515)

Wingtech FY2026 Q1 Earning Release on April 30 During-Market (BJT), Forecast Revenue CNY 3.715 B, EPS CNY 0.515

Wingtech to Release FY2025 Earnings on April 30 Pre-Market (BJT), Forecast Revenue CNY 33.79 B, EPS CNY 1.6268

Wingtech released FY2025 9 Months Earnings on October 24 During-Market (BJT), Actual Revenue CNY 29.77 B, Actual EPS CNY 1.2265

Wingtech released FY2025 Q3 earnings on October 24 During-Market (BJT), actual revenue CNY 4.427 B (forecast CNY 4.467 B), actual EPS CNY 0.8464 (forecast CNY 0.5526)

Wingtech to Release FY2025 Q3 Earnings on October 25 During-Market (BJT), Forecast Revenue CNY 4.467 B, EPS CNY 0.5526

Wingtech released FY2025 Q2 earnings on August 29 After-Market (BJT), actual revenue CNY 12.24 B (forecast CNY 9.445 B), actual EPS CNY 0.17 (forecast CNY 0.3428)

Wingtech released FY2025 Semi-Annual earnings on August 29 After-Market BJT, actual revenue CNY 25.34 B, actual EPS CNY 0.3799

Wingtech FY2025 Semi-Annual Earnings Release on August 30, 2025 (BJT)

Unitech Expected to See 178%-317% YoY Growth in Net Profit in H1 2025

Shareholders of Wunatek Plan to Reduce Shareholding

Unisplendour Corp Announces H1 2025 Earnings Forecast

Unisplendour Corp Expected to See Significant Profit Growth in First Half of 2025

Wenay Technology's ESG Rating Dropped to BBB

Unisoc Pushes Asset Restructuring and Increases Stock Repurchase

Unisem Holding's Q1 2025 Earnings Briefing

Unisplendour Corp. Q1 2025 Net Profit Surges 82.29%

Wen Tech Science Shareholder Plans to Reduce Shares

600745

000001

399001

399006

159903

159915

Three major Chinese stock indices closed higher, gaining between 1.1% and 3.5%, with total market turnover exceeding RMB 3.5 trillion. The Shanghai Composite Index rose to 4,225, marking its highest level since July 2015. The Shenzhen Component Index and ChiNext Index also saw significant gains. The People's Bank of China injected RMB 500 million through reverse repos, maintaining an operation rate of 1.4%. Notable performances were seen in chip stocks, while *ST WINGTECH faced a nearly 5% decline due to restricted control over Anshi.

AASTOCKS News

SSE Index

Shenzhen Index

ChiNext

China Southern Shenzhen Stock Exchange Component Stock ETF

E Fund GEM ETF

STAR 50

ICBC

BYD COMPANY

CATL

SMIC

Hua Hong

HUA HONG SEMI

Cambricon

MetaX

Moore Threads

Montage Technology

YOFC

BYD HK SDR 10to1

BYD Company

BYD Company Limited

BYD COMPANY-R

CATL HK SDR 30to1

SMIC HK SDR 5to1

MONTAGE TECH

3 Key CN Indices Gain 1.1-3.5% at End; SZ/ SH Mkt Turnover Tops RMB3.5T

Wingtech Technology, the Chinese owner of Nexperia, faces delisting risk from the Shanghai Stock Exchange due to an audit failure linked to a power struggle for control of its Dutch subsidiary. The auditor issued a disclaimer of opinion, citing issues in verifying Nexperia's overseas financial records. Wingtech's stock will be under delisting risk warning starting May 6, with potential trading halts. The company reported a 94% drop in first-quarter revenue and a net loss of 189 million yuan, exacerbated by disruptions in operations and halted shipments from Nexperia's offshore entities.

SCMP

Wingtech faces delisting risk after audit failure in wake of Nexperia saga

Jitaike (Beijing) Co., Ltd. has received the filing from the China Securities Regulatory Commission (CSRC) for its IPO on the Stock Exchange of Hong Kong, planning to issue no more than 273,495,000 ordinary shares for listing overseas. Concurrently, 39 shareholders will convert their total of 851,697,111 domestic unlisted shares into overseas listed shares for trading on the Stock Exchange of Hong Kong

Wallstreetcn

Jitaike's Hong Kong IPO Receives CSRC Filing

Nexperia China has commenced its own chip production, marking a step towards independence from its Dutch parent amid ongoing disputes affecting supply chains. The company announced it is manufacturing various chips using 12-inch wafers, which Nexperia cannot produce in Europe. This development follows a standoff with its owner Wingtech and a Dutch government intervention that disrupted operations. Nexperia China is now producing bipolar discrete devices, Schottky rectifiers, and electrostatic discharge devices, although the source of its 12-inch wafers remains unclear.

Businesstimes News

Nexperia China says it has begun producing its own chips

Nexperia China has announced a breakthrough in small-batch production of 12-inch wafer bipolar discrete devices, despite ongoing tensions with its Dutch headquarters. This achievement signifies a milestone in the Chinese subsidiary's independent R&D and mass production capabilities. The company, owned by China's Wingtech Technology, has faced geopolitical challenges since Dutch state intervention in 2022, which led to the imposition of a European management team.

Yahoo Finance

Nexperia China announces 12-inch wafer breakthrough as tensions with Dutch HQ persist

China's commerce ministry has warned that the Dutch side must be held accountable if the ongoing dispute between Nexperia and its Chinese subsidiary leads to another global chip supply crisis. The ministry stated that Nexperia's actions have disrupted normal operations, and if this escalates, the Dutch side will bear full responsibility. Nexperia's Chinese subsidiary accused the Dutch headquarters of disabling employee access to office accounts, causing significant operational disruptions. Despite diplomatic efforts to stabilize the situation, tensions remain, potentially threatening the global automotive semiconductor supply chain.

China warns of fresh chip crisis as Nexperia dispute flares up